Travere Therapeutics, Inc. (TVTX)
55.70
-1.97
(-3.42%)
USD |
NASDAQ |
Oct 06, 14:48
Travere Therapeutics Market Cap : 5.246B for Oct. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 05, 2026 | 5.431B |
| October 02, 2026 | 5.361B |
| October 01, 2026 | 5.354B |
| September 30, 2026 | 5.545B |
| September 29, 2026 | 5.650B |
| September 28, 2026 | 5.798B |
| September 25, 2026 | 5.598B |
| September 24, 2026 | 5.709B |
| September 23, 2026 | 5.634B |
| September 22, 2026 | 5.677B |
| September 21, 2026 | 5.920B |
| September 18, 2026 | 5.910B |
| September 17, 2026 | 6.097B |
| September 16, 2026 | 5.978B |
| September 15, 2026 | 5.887B |
| September 14, 2026 | 6.196B |
| September 11, 2026 | 6.232B |
| September 10, 2026 | 6.358B |
| September 09, 2026 | 6.236B |
| September 08, 2026 | 6.222B |
| September 04, 2026 | 6.148B |
| September 03, 2026 | 6.266B |
| September 02, 2026 | 6.331B |
| September 01, 2026 | 6.188B |
| August 31, 2026 | 6.242B |
| Date | Value |
|---|---|
| August 28, 2026 | 6.184B |
| August 27, 2026 | 6.359B |
| August 26, 2026 | 6.321B |
| August 25, 2026 | 6.311B |
| August 24, 2026 | 6.142B |
| August 21, 2026 | 6.188B |
| August 20, 2026 | 6.071B |
| August 19, 2026 | 6.212B |
| August 18, 2026 | 6.018B |
| August 17, 2026 | 5.983B |
| August 14, 2026 | 5.852B |
| August 13, 2026 | 5.785B |
| August 12, 2026 | 5.854B |
| August 11, 2026 | 5.670B |
| August 10, 2026 | 5.734B |
| August 07, 2026 | 5.775B |
| August 06, 2026 | 5.881B |
| August 05, 2026 | 5.910B |
| August 04, 2026 | 5.276B |
| August 03, 2026 | 5.178B |
| July 31, 2026 | 5.164B |
| July 30, 2026 | 5.293B |
| July 29, 2026 | 5.134B |
| July 28, 2026 | 5.166B |
| July 27, 2026 | 5.237B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioMarin Pharmaceutical, Inc. | 10.86B |
| TG Therapeutics, Inc. | 8.037B |
| Krystal Biotech, Inc. | 9.672B |
| RenovoRx, Inc. | 63.17M |
| Pelthos Therapeutics, Inc. | 81.96M |
Market Cap Related Metrics
| PS Ratio | 8.907 |
| Price to Book Value | 213.91 |
| Price to Free Cash Flow | 342.05 |
| Price | 55.70 |
| Earnings Yield | -1.37% |